Código QR (código de barras bidimensional)

Targeting histone deacetylases for cancer therapy: Trends and challenges

Dysregulation of histone deacetylases (HDACs) is closely related to tumor development and progression. As promising anticancer targets, HDACs have gained a great deal of research interests and two decades of effort has led to the approval of five HDAC inhibitors (HDACis). However, currently traditio...

ver descrição completa

Na minha lista:
Principais autores: Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2023-06-01
coleção:Acta Pharmaceutica Sinica B
Assuntos:
HDACs
Oncogenesis
Selective inhibitor
Combination therapy
Multitarget agent
PROTAC
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2211383523000345
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados